Marcello Damiani
Directeur/Membre du Conseil chez Cellarity Inc.
Provenance du réseau au premier degré de Marcello Damiani
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 47 | |
21
| Public Company | Medical Specialties | 21 |
12
| Public Company | Biotechnology | 12 |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA.
12
| Holding Company | Biotechnology | 12 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA.
7
| Subsidiary | Biotechnology | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Marcello Damiani via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Chief Executive Officer Private Equity Investor Private Equity Investor Consultant / Advisor Chief Executive Officer Private Equity Investor Private Equity Analyst | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Doctorate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree Graduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Founder Human Resources Officer | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member | |
| SERES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder Director/Board Member Chairman | |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Biotechnology | Founder Director/Board Member Founder Founder | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Public Communications Contact Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Columbia Law School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| QIAGEN N.V. | Medical Specialties | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Director/Board Member Consultant / Advisor Consultant / Advisor | |
| PFIZER, INC. | Pharmaceuticals: Major | President Public Communications Contact Corporate Officer/Principal | |
| ONCORUS, INC. | Biotechnology | Chief Executive Officer Chief Operating Officer Director of Finance/CFO | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member Founder Founder | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| TRANSGENE | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Boston University | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder Founder | |
| BIOGEN INC. | Pharmaceuticals: Major | Public Communications Contact Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BG MEDICINE, INC. | Medical Specialties | Founder Chairman President | |
bioMERIEUX Benelux SANV
 bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
BenevolentAI Ltd.
 BenevolentAI Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Ltd. develops artificial intelligence applications. The company is based in London, UK. The British company was founded in 2015 by Kenneth Patrick Mulvany, Ivan Griffin, Michael Brennan. BenevolentAI was acquired by Odyssey Acquisition SA on April 22, 2022 for $1,087.33 million. | Packaged Software | Chairman Chief Executive Officer Director/Board Member | |
| Dartmouth College | College/University | Masters Business Admin Undergraduate Degree | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| MIT Sloan School of Management | College/University | Graduate Degree Masters Business Admin | |
Epiva Biosciences, Inc.
 Epiva Biosciences, Inc. BiotechnologyHealth Technology Epiva Biosciences, Inc. develops immunobiotic therapeutics. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
Inzen Therapeutics, Inc.
 Inzen Therapeutics, Inc. BiotechnologyHealth Technology Part of Sonata Therapeutics, Inc., Inzen Therapeutics, Inc. is discovering and developing a novel class of medicines based on thanokine biology. The company is based in Cambridge, MA. Thanokine biology offers the potential for unprecedented approaches to prevent and treat cancer, fibrotic disorders, immune-inflammatory disorders, metabolic disorders, and degenerative diseases. Inzen's thanokine product platform applies advances in mass spectrometry and machine learning, novel probes, unique assays, genetic and chemical biological technologies to characterize thanokine biology at scale and create drug candidates. Inzen Therapeutics harnesses signals of the cellular microenvironment to treat serious diseases. The company was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability. | Biotechnology | Director/Board Member Director/Board Member | |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Goodwin Procter LLP is a law firm which provides advice to companies in public and private enterprises. It provides services to financial, life sciences, private equity, real estate, and technolgy industries. The company was founded in 1912 and is headquartered in Boston, MA. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Public Communications Contact Chief Tech/Sci/R&D Officer | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Director of Finance/CFO Sales & Marketing | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VAXCYTE, INC. | Biotechnology | Director/Board Member Chairman | |
| DNIB UNWIND INC | Biotechnology | Director/Board Member Director/Board Member | |
YourBio Health, Inc.
 YourBio Health, Inc. Electronic Equipment/InstrumentsElectronic Technology YourBio Health, Inc. develops health monitoring products. It is developing an array of products based on the company's proprietary TAP? (Touch Activated Phlebotomy) painless blood collection platform. The company was founded by Richard Rox Anderson, Joerg Lahann, Robert S. Langer Jr., Douglas A. Levinson and Samir Mitragotri in 2008 and is headquartered in Medford, MA. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 41 |
| France | 4 |
| Royaume-Uni | 3 |
| Canada | 2 |
| Pays-Bas | 2 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 12 |
| Finance | 5 |
| Commercial Services | 4 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 466 |
| Corporate Officer/Principal | 220 |
| Independent Dir/Board Member | 126 |
| Founder | 77 |
| Chairman | 63 |
Relations les plus connectées
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Peter Hutt | 69 |
| Paul Sagan | 38 |
| Elizabeth Nabel | 31 |
| Elizabeth Tallett | 28 |
| Francois Nader | 28 |
| Theo Melas-Kyriazi | 26 |
| Harold Y. H. Boël | 26 |
| James Collins | 25 |
| Agnès Lemarchand | 25 |
| David Meline | 24 |
| Stéphane Bancel | 23 |
| Olivier Brandicourt | 23 |
| Moncef Slaoui | 22 |
| Marie-Hélène Habert-Dassault | 22 |
- Bourse
- Insiders
- Marcello Damiani
- Connexions Sociétés
